Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy

European Journal of Cancer

Volumn 41, Issue 5, 2005, Pages 727-734

  Taylor, Roger E ^a   Bailey, Clifford C ^b   Robinson, Kathryn J ^c   Weston, Claire L ^c   Walker, David A ^d   Ellison, David ^e   Ironside, James ^f   Pizer, Barry L ^g   Lashford, Linda S ^h  

^a Northern and Yorkshire Clinical Trials and Research Unit   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d QUEEN S MEDICAL CENTRE   (United Kingdom)

^e NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

^g ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

^h Cancer Research   (United Kingdom)

Author keywords

Chemotherapy; Medulloblastoma; Metastases; Outcome; Radiotherapy; Survival

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; MESNA; VINCRISTINE;

ADOLESCENT; AGE DISTRIBUTION; ANEMIA; ARTICLE; BRAIN HEMORRHAGE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHILD; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIARRHEA; DRUG DOSE REGIMEN; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; METASTASIS; NEUROECTODERM TUMOR; NEUTROPENIA; PERIPHERAL NEUROPATHY; PNEUMONIA; POSTERIOR FOSSA; PRIORITY JOURNAL; RADIATION DOSE; SEX ROLE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 14844331808     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2004.12.017     Document Type: Article

References (18)

1. C.H. Chang, E.M. Housepian, and C. Herbert An operative staging system and a megavoltage radiotherapeutic technique for cerebellar medulloblastoma Radiology 93 1969 1351 1359
2. R.J. Packer, J. Goldwein, and H.S. Nicholson Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: a children's cancer group study J Clin Oncol 17 1999 2127 2136
3. R.E. Taylor, C.C. Bailey, and K. Robinson Results of a randomised study of pre-radiation chemotherapy vs radiotherapy alone for non-metastatic (M0-1) medulloblastoma. The SIOP/UKCCSG PNET-3 study J Clin Oncol 21 2003 1581 1591
4. J.-.C. Gentet, F. Doz, and E. Bouffet Carboplatin and VP 16 in medullblastoma: a phase II study Med Pediatr Oncol 23 1994 422 427
5. C.C. Bailey, A. Gnekow, and S. Wellek Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the German Society of Paediatric Oncology (GPO): SIOP II Med Pediatr Oncol 2 1995 166 178
6. R.-.D. Kortmann, J. Kuhl, and B. Timmermann Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomised trial HIT '91 Int J Radiat Oncol Biol Phys 46 2000 269 279
7. P.M. Zeltzer, J.M. Boyett, and J.L. Finlay Metastasis, stage, adjuvant treatment, and residual are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study J Clin Oncol 17 1999 832 845
8. R.E. Taylor, H. Lucraft, and C.C. Bailey Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology (SIOP)/United Kingdom Children's Cancer Study Group (UKCCSG) PNET-3 study of pre-radiotherapy chemotherapy for M0-1 medulloblastoma Int J Radiat Oncol Biol Phys 58 2004 1184 1193
9. P.C.W. Kleihues Tumors of the nervous system. World Health Organization classification of tumors 2000 IARC Lyon
10. E.L. Kaplan, and P. Meier Non parametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 482
11. C.R. Freeman, R.E. Taylor, and R.D. Kortmann Radiotherapy for medulloblastoma in children: an international perspective on current clinical research efforts Med Pediatr Oncol 39 2002 99 108
12. R.K. Mulhern, and J.L. Kepner Neuropsychologic functioning of survivors of childhood medulloblastoma randomised to receive conventional or reduced-dose craniospinal irradiation: a pediatric oncology group study J Clin Oncol 16 1998 1723 1728
13. J.C. Gentet, E. Bouffet, and F. Doz Pre-irradiation chemotherapy including 'eight drugs in 1 day' regimen and high-dose methotrexate in childhood medulloblastoma: results of the M7 French Cooperative Study J Neurosurg 82 1995 608 614
14. N.J. Tarbell, H. Friedman, and J. Kepner Outcome for children with high stage medulloblastoma: results of the Pediatric Oncology Group 9031 study Int J Radiat Oncol Biol Phys 48 Suppl. 2000 179
15. J. Grill, V. Kieffer Renaux, and C. Bulteau Long-term intellectual outcome in children with posterior fossas according to radiation doses and volumes Int J Radiat Oncol Biol Phys 45 1999 137 145
16. J.O. del-Charco, T.W. Bolek, and W.M. McCollough Medulloblastoma: time-dose relationship based on a 30-year review Int J of Radiat Oncol Biol Phys 42 1998 147 154
17. T.E. Wheldon, J.A. O'Donoghue, and A. Barrett Kinetic considerations in the choice of treatment schedules for neuraxis radiotherapy Br J Radiol 66 1993 61 66
18. L. Gandola, G. Cefalo, and M. Massimino Hyperfractionated accelerated radiotherapy (HART) for metastatic medulloblastoma Neuro-Oncology 5 2003 39 40